KIR3DL2 expression in patients with adult T-cell lymphoma/leukaemia

Br J Dermatol. 2018 Jul;179(1):197-199. doi: 10.1111/bjd.16322. Epub 2018 May 9.

Authors

C Hurabielle^{1

2}, C Leboeuf³, C Ram-Wolff¹, V Meignin⁴, J Rivet⁴, M-D Vignon-Pennamen⁴, C Bonnafous⁵, H Sicard⁵, C Fite⁶, E Raffoux⁷, B Arnulf⁸, E Oksenhendler⁸, F Sicre de Fontbrune⁹, R Peffault de Latour⁹, G Socié⁹, J-D Bouaziz^{1

2

10}, C Lebbé^{1

2

3

10}, A Bensussan^{2

10}, A Janin^{3

4

10}, M Bagot^{1

2

10}, M Battistella^{3

4

10}

Affiliations

¹ Service de Dermatologie, Hôpital Saint-Louis, AP-HP, Paris, France.
² Inserm Unité 976, Hôpital Saint-Louis, AP-HP, Paris, France.
³ Université Paris Diderot, INSERM UMRS1165, Paris, France.
⁴ Service D'Anatomo-Pathologie, Hôpital Saint-Louis, AP-HP, Paris, France.
⁵ Innate Pharma, Marseille, France.
⁶ Service de Dermatologie, Hôpital Bichat, AP-HP, Paris, France.
⁷ Service d'Hématologie, Hôpital Saint-Louis, AP-HP, Paris, France.
⁸ Service d'Immuno-Hématologie, Hôpital Saint-Louis, AP-HP, Paris, France.
⁹ Service d'Hématologie-Greffe, Hôpital Saint-Louis, AP-HP, Paris, France.
¹⁰ Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

PMID: 29315492
DOI: 10.1111/bjd.16322

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Female
Humans
Leukemia-Lymphoma, Adult T-Cell / mortality
Leukemia-Lymphoma, Adult T-Cell / pathology*
Male
Middle Aged
Receptors, KIR3DL2 / metabolism*
Skin / cytology
Skin / pathology
Skin Neoplasms / mortality
Skin Neoplasms / pathology*
Survival Analysis

Substances

KIR3DL2 protein, human
Receptors, KIR3DL2